An Investigation of the Efficacy and Safety of Favipiravir in COVID-19 Patients without Pneumonia − An open-label randomized controlled study
Latest Information Update: 25 Nov 2020
At a glance
- Drugs Favipiravir (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
- 25 Nov 2020 New trial record